{
    "2019-09-20": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Pharmaceutical Companies to Consider as Lawmakers Continue to Fight for Lower Drug Prices",
                "features": {
                    "keywords": [
                        "pharmaceutical",
                        "lawmakers",
                        "lower drug prices"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-11-20",
                "original_text": "CHMP Issues Positive Opinion to Expand TrulicityÂ® (dulaglutide) Label to Include Results from REWIND Cardiovascular Outcomes Trial",
                "features": {
                    "keywords": [
                        "CHMP",
                        "positive opinion",
                        "Trulicity",
                        "dulaglutide",
                        "REWIND trial",
                        "cardiovascular outcomes"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}